Skip to main navigation Skip to search Skip to main content

Evaluation of a Standardised Treatment Regimen of Anti-tuberculosis Drugs in Patients with Multidrug-resistant Tuberculosis

  • Laura Rosu

Research output: Contribution to conferencePaper

Abstract

Presentation

Original languageEnglish
Publication statusPublished - 8 Nov 2022
EventWorld Conference on Lung Health 2022 -
Duration: 8 Nov 202211 Nov 2022

Conference

ConferenceWorld Conference on Lung Health 2022
Period8/11/2211/11/22

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Evaluation of a Standardised Treatment Regimen of Anti-tuberculosis Drugs in Patients with Multidrug-resistant Tuberculosis'. Together they form a unique fingerprint.

Cite this